Condition: Acute Ischemic Stroke · Cerebral Autoregulation · Sponsor: Beijing Shijitan Hospital, Capital Medical University
This multicenter, prospective, observational diagnostic accuracy study enrolls patients undergoing thrombectomy with intraoperative cerebral autoregulation monitoring and follows them up at predefined time points up to 90 days post-enrollment. The study aims to determine whether impaired cerebral autoregulation during thrombectomy can serve as an ultra-early biomarker for predicting futile recanalization in patients with acute ischemic stroke.
This description comes directly from the study's public registry record.
Zidong Li · 010-63925615 · walx592815088@163.com
Shen Li · 010-63925616 · lishen@mail.ccmu.edu.cn
Always discuss trial participation with your own doctor first.
| Beijing Shijitan Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of Harbin Medical University | Harbin, Heilongjiang, China | Recruiting |
| Dalian Municipal Central Hospital | Dalian, Liaoning, China | Not Yet Recruiting |
| Weifang People's Hospital Affiliated to Weifang Medical University | Weifang, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07556068